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Hospital Negrar, Verona, Italy; and f Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology,
Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PennsylvaniaObjective: To evaluate the effect of endometriosis on pregnancy outcomes.
Design: Systematic review and meta-analysis.
Setting: Not applicable.
Patient(s): Women with or without endometriosis.
Intervention(s): Electronic databases searched from their inception until February 2017 with no limit for language and with all cohort
studies reporting the incidence of obstetric complications in women with a diagnosis of endometriosis compared with a control group
(women without a diagnosis of endometriosis) included.
Mean Outcome Measure(s): Primary outcome of incidence of preterm birth at <37 weeks with meta-analysis performed using the
random effects model of DerSimonian and Laird to produce an odds ratio (OR) with 95% conﬁdence interval (CI).
Result(s): Twenty-four studies were analyzed comprising 1,924,114 women. In most of them, the diagnosis of endometriosis was made
histologically after surgery. Women with endometriosis had a statistically signiﬁcantly higher risk of preterm birth (OR 1.63; 95% CI,
1.32–2.01), miscarriage (OR 1.75; 95% CI, 1.29–2.37), placenta previa (OR 3.03; 95% CI, 1.50–6.13), small for gestational age (OR 1.27;
95% CI, 1.03–1.57), and cesarean delivery (OR 1.57; 95% CI, 1.39–1.78) compared with the healthy controls. No differences were found
in the incidence of gestational hypertension and preeclampsia.
Conclusion(s): Women with endometriosis have a statistically signiﬁcantly higher risk of preterm birth, miscarriage, placenta previa,
small for gestational age infants, and cesarean delivery. (Fertil Steril 2017;-:-–-. 2017 by American Society for Reproductive
Medicine.)
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16110-fertility-and-sterility/posts/18598-24466E ndometriosis, an estrogen-dependent chronic gynecologicdisease, affects about 10% of
women in the general population and
about 40% of women with a history of
subfertility or pelvic pain (1). It is deﬁnedReceived June 2, 2017; revised July 16, 2017; accepte
F.Z. has nothing to disclose. E.S. has nothing to disclo
to disclose. S.X. has nothing to disclose. M.C. has
Reprint requests: Vincenzo Berghella, M.D., Depart
Maternal-Fetal Medicine, Thomas Jefferson Uni
sylvania 19107 (E-mail: vincenzo.berghella@jeff
Fertility and Sterility® Vol.-, No.-,- 2017 0015-
Copyright ©2017 American Society for Reproductive
http://dx.doi.org/10.1016/j.fertnstert.2017.07.019
VOL.- NO.- /- 2017by the presence of endometrium-like tis-
sue outside the uterus, including on the
ovaries and in the fallopian tube and
the posterior cul-de-sac (2). The main
symptoms are pelvic pain and infertility.
Pain during sex is also common. The lessd July 17, 2017.
se. G.S. has nothing to disclose. M.A. has nothing
nothing to disclose. V.B. has nothing to disclose.
ment of Obstetrics and Gynecology, Division of
versity, 833 Chestnut Street, Philadelphia, Penn-
erson.edu).
0282/$36.00
Medicine, Published by Elsevier Inc.common symptoms include urinary or
bowel symptoms (3).
Traditionally, pregnancy was
considered to have a positive effect on
endometriosis and its symptoms,
including the pain (1). However, the path-
ophysiology of endometriosis is not well
understood, and its impact on pregnancy
is relatively unexplored (4, 5). Several
observational nonrandomized studies
evaluating the effect of endometriosis
on pregnancy outcomes have been
published, so far with conﬂicting
results. Our systematic review and
meta-analysis evaluated the effect of
endometriosis on pregnancy outcomes.1
ORIGINAL ARTICLE: ASSISTED REPRODUCTIONMATERIALS AND METHODS
Search Strategy
Electronic databases (Medline, Scopus, ClinicalTrials.gov,
EMBASE, Sciencedirect) were searched from their inception
until February 2017 with no limit for language. The search
terms used were the following: ‘‘preterm,’’ ‘‘placental disor-
ders,’’ ‘‘endometriosis,’’ ‘‘infertility,’’ ‘‘pre-eclampsia,’’ ‘‘preg-
nancy hypertension,’’ ‘‘pregnancy,’’ ‘‘population based
studies,’’ ‘‘complications,’’ and ‘‘obstetric outcome.’’ No re-
strictions for language or geographic location were applied.
In addition, the reference lists of all identiﬁed articles were
examined to identify any studies not captured by the elec-
tronic searches. The electronic search and the eligibility of
the studies were independently assessed by two of the authors
(F.Z., E.S.). The differences were discussed with a third
reviewer (V.B.).Study Selection
We included all cohort studies reporting the incidence of
obstetric complications in women with a diagnosis of
endometriosis compared with a control group of women
without a diagnosis of endometriosis. Studies without a
control group were excluded. Case-control studies, report-
ing the incidence of endometriosis in women with obstetric
complications, were also excluded. The diagnosis of endo-
metriosis included surgical, clinical, or instrumental (ultra-
sound, magnetic resonance imaging, or computed
tomography scan) diagnosis.
Two authors (F.Z., E.S.) independently assessed the inclu-
sion criteria and study selection. Disagreements were resolved
by discussion with a third reviewer (V.B.).
Data abstraction was completed by two independent in-
vestigators (F.Z., V.B.). Each investigator independently
abstracted data from each study separately. Data from each
eligible study were extracted without modiﬁcation of the
original data onto custom-made data collection forms. Differ-
ences were resolved by consensus. Information on con-
founders adjusted and adjusted risk estimates were collected
when available.Primary and Secondary Outcomes
Primary and secondary outcomes were planned a priori. The
primary outcome was the incidence of preterm birth (PTB)
at less than 37 weeks. Secondary outcomes were PTB at
<34 weeks, incidence of miscarriage (deﬁned as spontaneous
abortion at<22 weeks), gestational hypertension, preeclamp-
sia, placenta previa and accreta, small for gestational age
(SGA, deﬁned as birth weight <10th percentile for the gesta-
tional age), and cesarean delivery. If outcomes were reported
in the original studies for more the one pregnancy, only the
ﬁrst pregnancy after the diagnosis of endometriosis was
considered for the meta-analysis.
We planned a sensitivity analysis for the primary
outcome (i.e., incidence of PTB at <37 weeks) according
to the study design. We also planned to assess the incidence
of PTB in subgroup analyses of only assisted reproductive2technology (ART) and non-ART women, and according to
the type of endometriosis.Risk of Bias
The risk of bias of the included studies was assessed via the
Methodological Index for Non-Randomized Studies (MI-
NORS). Seven domains related to risk of bias were assessed
in each study: [1] aim (i.e., clearly stated aim), [2] rate (i.e.,
inclusion of consecutive patients and response rate), [3]
data (i.e., prospective collection of data or data collected us-
ing a high-quality population-based data set), [4] bias (i.e.,
unbiased assessment of study end points), [5] time (i.e.,
follow-up time appropriate), [6] loss (i.e., loss to follow-
up), and [7] size (i.e., calculation of the study size) (6). The re-
view authors’ judgments were categorized as ‘‘low risk,’’
‘‘high risk,’’ or ‘‘unclear risk of bias.’’ Discrepancies were
resolved by discussion.
Two authors (FZ, GS) independently assessed the risk of
bias. Disagreements were resolved by discussion with a third
reviewer (VB).Statistical Analysis
The data analysis was completed independently by two au-
thors (FZ, GS) using Review Manager version 5.3 (Nordic Co-
chrane Centre, Cochrane Collaboration, Denmark). The
completed analyses were then compared, and any differences
were resolved by discussion with a third reviewer (V.B.).
Data from each eligible study were extracted without
modiﬁcation onto custom-made data collection forms.
A 2 2 table was assessed for the odds ratio (OR); for contin-
uous outcomes the mean  standard deviation was extracted
and imported into Review Manager version 5.3 (Nordic Co-
chrane Centre, Cochrane Collaboration, 2014, Copenhagen,
Denmark).
The meta-analysis was performed using the random ef-
fects model of DerSimonian and Laird, to produce summary
treatment effects in terms of OR with 95% conﬁdence interval
(CI) (7). Heterogeneity was measured using I-squared (Higgins
I2) (8, 9). Potential publication biases were assessed
statistically by using Begg's and Egger's tests (8). P< .05
was considered statistically signiﬁcant.
The meta-analysis was reported following the Preferred
Reporting Item for Systematic Reviews and Meta-analyses
(PRISMA) statement (10). The review was registered with the
PROSPERO International Prospective Register of Systematic
Reviews (registration no. CRD42017057259).
RESULTS
Study Selection and Study Characteristics
We assessed 34 studies for eligibility (4, 11–43). Ten studies
were excluded (30–34, 36–38, 44). Three were excluded
because they did not have a control group (30, 33, 36). Four
were excluded because they were case-control studies (31,
32, 35, 37). One was excluded because they included in the
intervention group all types of infertility rather than only
women with endometriosis (34). One was excluded because
it was a review (38). Another one was excluded due to theVOL.- NO.- /- 2017
FIGURE 1
Forest plot for the risk of preterm birth at less than 37 weeks. M-H = Mantel-Haenszel test; CI ¼ conﬁdence interval.
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Fertility and Sterility®lack of outcome of interest (43). Therefore, 24 studies, which
included 1,924,114 women, were analyzed (4, 11–29, 39–42)
(Supplemental Fig. 1, available online). Out of the 1,924,114
women included, 52,111 (2.7%) had a prior diagnosis of
endometriosis before pregnancy, and 1,872,003 (97.3%)
were included in the control group (Supplemental Table 1,
available online).
Most of the included studies clearly stated the aim of the
research and were judged as low risk of bias in their aim.
Given that the majority of them were retrospective studies,
they had a high risk of bias in their data. Appropriate
follow-up observations were found in most of the studies.
The sample sizes ranged from 88 (a high risk of bias in size)
to 1,442,675 (a low risk of bias in size) (Supplemental
Fig. 2, available online). The publication bias, assessed using
Begg's and Egger's tests, was not statistically signiﬁcant
(P¼ .81 and .83, respectively).
Most of the included studies came from Europe (19 of 24,
79%). Three (12.5%) came from the United States. Two (8%)
studies were prospective cohort studies, 13 (54%) were retro-
spective cohort, and 9 (38%) were high-quality population-
based studies (see Supplemental Table 1).
In all the studies, the diagnosis of endometriosis was
made before pregnancy. In 21 studies the diagnosis of
endometriosis was made histologically after surgery; in
three studies it was determined based on the relevant
ICD codes. In 14 studies, all women included in the anal-
ysis underwent assisted reproductive techniques (ART): in
the intervention group for endometriosis, and in the con-
trol group for reasons other than endometriosis (including
tubal factor, male factor, or unexplained infertility). Nine
studies included also women who did not undergo ART.
Finally, Lin et al. (26) included only women who did not
undergo ART in both the endometriosis and control
groups.VOL.- NO.- /- 2017Twenty-one studies included any type of endometriosis;
one study included only women with ovarian endometrioma,
one included only women with deep inﬁltrating endometri-
osis, and another study included superﬁcial, ovarian, and
deep inﬁltrating endometriosis (Supplemental Table 2, avail-
able online).Synthesis of Results
Compared with the control group, women who had a prior
diagnosis of endometriosis had a statistically signiﬁcantly
higher risk of PTB at <37 weeks (OR 1.63; 95% CI, 1.32–
2.01) (Fig. 1), of PTB at <34 weeks (OR 1.58; 95% CI, 1.09–
2.67), and of miscarriage (OR 1.75; 95% CI, 1.29–2.37)
(Fig. 2). No differences were found in the incidence of gesta-
tional hypertension (OR 0.90; 95% CI, 0.59–1.37)
(Supplemental Fig. 3, available online) or preeclampsia (OR
1.04; 95% CI, 0.83–1.29) (Supplemental Fig. 4, available on-
line). Women with endometriosis had also a statistically
signiﬁcantly higher risk of placenta previa (OR 3.03; 95%
CI, 1.50–6.13) (Supplemental Fig. 5, available online), SGA
(OR 1.27; 95% CI, 1.03–1.57) (Fig. 3), and cesarean delivery
(OR 1.57; 95% CI, 1.39–1.78) (Fig. 4). Data on placenta accreta
were not available.
The sensitivity analysis for only retrospective cohort
studies (OR 2.05; 95% CI, 1.24–3.38; 10 studies, 30,635 partic-
ipants) and for only population-based studies (OR 1.30; 95%
CI, 1.23–1.39; 4 studies, 1,486,489 participants) both
concurred with the overall analysis ﬁnding an increase in
PTB at <37 weeks.
The subgroup analysis of only the women who underwent
ART concurred with the overall analysis in the increase in PTB
(OR 1.26; 95% CI, 1.13–1.76; 6 studies, 28,121 participants). A
subgroup analysis for the non-ART women was not feasible
because the data were not reported separately for this group.3
FIGURE 2
Forest plot for the risk of miscarriage. M-H = Mantel-Haenszel test; CI ¼ conﬁdence interval.
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not feasible because the vast majority of studies reported all
types of endometriosis together with no stratiﬁcation of
data by type; the three studies that did report on the type of
endometriosis reported different types (see Supplemental
Table 2).DISCUSSION
Main Findings
This meta-analysis, from 24 studies, including 1,924,114
women, evaluated the effect of endometriosis on future
pregnancy outcome. We found that endometriosis was an
independent risk factor for PTB, miscarriage, placenta pre-
via, SGA, and cesarean delivery. Sensitivity and subgroup
analyses for the primary outcome for type of study and
for ART women only both concurred with the overall
analysis.FIGURE 3
Forest plot for the risk of small for gestational age. M-H = Mantel-Haensze
Zullo. Pregnancy complications with endometriosis. Fertil Steril 2017.
4Comparison with Existing Literature
A prior review by Leone Roberti Maggiore et al. (5) aimed to
study the effect of pregnancy on endometriosis and hypothe-
sized mechanisms to explain the underlying relationships.
They found that complications of endometriosis during preg-
nancy were rare, but the effect of endometriosis on pregnancy
outcomes was not well evaluated.Strengths and Limitations
Our study has several strengths. To our knowledge, no prior
meta-analysis on this issue is as large, up to date, or compre-
hensive. The number of the included women is large. We
planned sensitivity and subgroup analyses to reduce the het-
erogeneity between the studies.
The limitations of our study are inherent to the limitations
of the included studies. Diagnosis and management of preg-
nancy complications (e.g., preeclampsia) could differ acrossl test; CI ¼ conﬁdence interval.
VOL.- NO.- /- 2017
FIGURE 4
Forest plot for the risk of cesarean delivery. M-H = Mantel-Haenszel test; CI ¼ conﬁdence interval.
Zullo. Pregnancy complications with endometriosis. Fertil Steril 2017.
Fertility and Sterility®the studies. Most outcomes had very high statistical heteroge-
neity. Given the limited data, subgroup analyses of only the
non-ART women and according to the type of endometriosis
were not feasible. In several studies, adjustment was made for
potential confounders, but in other studies no such adjust-
ment was indicated. Lack of information on stage and out-
comes, treatment and outcomes, and ART and outcomes
were the major shortcomings of the meta-analysis. Only
one study reported data on PTB at <32 weeks, so a meta-
analysis for this outcome was not feasible.Implications
Endometriosis, a disease associated with pelvic pain, subfer-
tility, and impaired quality of life, affects many women
around the globe. The pathophysiology of endometriosis re-
mains poorly understood. To date, no studies have been per-
formed on biopsies of the placental bed in women with
endometriosis to investigate any potential changes in the
development of the uteroplacental circulation. However,
several clinical studies have reported an association between
endometriosis and subsequent pregnancy complications.
Our meta-analysis showed that women with diagnosed
endometriosis (mostly via surgery) had poorer pregnancy out-
comes, with a statistically signiﬁcantly increased risk of PTB,
miscarriage, placenta previa, SGA, and cesarean delivery. Hy-
pertensive disorders, including gestational hypertension and
preeclampsia, seem not to be inﬂuenced by endometriosis.
In human pregnancies the implantation of the blastocyst
into a receptive endometrium, successful placentation, and
remodeling of the uterine vasculature require the integration
of a number of critical stages. Dysfunction may occur in
several stages of the process, and pregnancy complications
are thought to depend on the dysregulation of such events
(44). In women affected by endometriosis, several adverse
events may occur in the peri-implantation period as well as
throughout the pregnancy, including endometrial resistanceVOL.- NO.- /- 2017to selective actions of progesterone, inﬂammatory processes
at the endometrial and systemic levels, inadequate uterine
contractility, and endometrial excessive activation of free
radical metabolism (45–49). All these alterations of the
local endometrial environment have been described in
women with endometriosis as well as in women at risk of
preterm labor, fetal growth restriction, and placental
disorders (31, 50).Conclusions
Women with endometriosis have a statistically signiﬁcantly
higher risk of PTB, miscarriage, placenta previa, SGA, and ce-
sarean delivery. This information might be helpful for women
and their providers when managing these pregnancies.
Further studies are required to assess whether any modiﬁca-
tion is needed to conventional pregnancy monitoring for pa-
tients with endometriosis.REFERENCES
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SUPPLEMENTAL FIGURE 1
Flow diagram of studies identiﬁed in the systematic review. (Prisma
template [Preferred Reporting Item for Systematic Reviews and
Meta-analyses]).
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SUPPLEMENTAL FIGURE 2
Assessment of risk of bias. (A) Summary of risk of bias for each trial; Plus sign: low risk of bias; minus sign: high risk of bias; question mark: unclear
risk of bias. (B) Risk of bias graph about each risk of bias item presented as percentages across all included studies.
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SUPPLEMENTAL FIGURE 3
Forest plot for the risk of gestational hypertension. M-H = Mantel-Haenszel test; CI ¼ conﬁdence interval.
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SUPPLEMENTAL FIGURE 4
Forest plot for the risk of preeclampsia. M-H = Mantel-Haenszel test; CI ¼ conﬁdence interval.
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SUPPLEMENTAL FIGURE 5
Forest plot for the risk of placenta previa. M-H = Mantel-Haenszel test; CI ¼ conﬁdence interval.
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